Delpharm Poznań S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-05-25
Share capital
147,893,140.00 PLN
Average employment (people)
749 (2025)
Activity description

Delpharm Poznań is a leading CDMO specializing in the development and manufacturing of pharmaceuticals for the pharmaceutical industry. The company offers expertise in solid, sterile, semi-solid, and liquid forms, with a particular focus on nasal spray production, providing flexible manufacturing capabilities and diverse packaging options. Delpharm operates multiple production sites in Europe and North America, ensuring high-quality and compliant therapeutic solutions.

Registered address
Grunwaldzka 189, 60-322 Poznań, Poland
Email
Social media
Electronic delivery address
AE:PL-72325-89290-SDHRD-16

Financials

Financial insight

  • Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

From the notes

Current income tax (CIT due)$928,065
Profit allocationNo decision
Capital expenditure$4,204,493
Planned capital expenditure (next year)$6,654,947
Foreign sales99.21% of revenue ($105,830,435)
Revenue structureWyroby gotowe

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 88 days late). All were audited by a statutory auditor.

  • 202524/11/2025
  • 202410/12/2024
  • 202321/12/2023
  • 202111/10/2022
  • 202030/09/2021
  • 201908/09/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 6.5%
Sector · Manufacturing673 / 24,548
Top 2.7%
City · Poznań64 / 11,701
Top <1%
Voivodeship · Wielkopolskie239 / 30,850
Top <1%
Country · Poland2,059 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 110.90mMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD 1.55mMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 104.83mMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 199.83mMedianUSD 897.46kAverageUSD 31.52m

Offer

  • Drug development
  • Medicine production
  • Drug testing
  • Pre-filled syringe filling
  • Nasal spray manufacturing
  • Liquid medicine manufacturing

Websites

  • delpharm.comDelpharm - Fabrication développement de médicaments CDMO

Authorized Representatives

Kamilla Agnieszka Niedzielska age 53 – President of the Management Board
Agnieszka Koplin age 53 – Management Board Member
Kamila Anna Sosnowska age 52 – Attorney-in-fact (joint)
Waldemar Piotr Mandziuk age 47 – Management Board Member
Sławomir Wieliński age 58 – Attorney-in-fact (joint)

Manner of representation

To make declarations of will on behalf of the company and sign documents on its behalf, joint action by two members of the management board or one member of the management board jointly with a commercial proxy is required.

Supervisory board

Sébastien Aguettant – Supervisory Board Member
Nicolas Leforestier – Supervisory Board Member
Nicolas Ragot – Supervisory Board Member

Ownership

Owner
Delpharm Industrie Sas

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1994-01-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$5.7M
Buildings and premises
$41.9M

Secured liabilities

Type
Pledge over the debtor’s assets

MSiG notices

Publication dateEvent
Nov 23, 2021Commercial Companies Code notice
Nov 4, 2021Demerger announced
Dec 1, 2014Commercial Companies Code notice

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$18,166
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$15,285

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Competitors

Change history

DateEvent
2022-06-30Name change
2001-05-28Name change
2001-05-25Entered in the register

FAQ

Last updated: 2026-11-03